More importantly, CXCL11 and CXCL12 were able to attenuate the expression of endogenous ARGs, demonstrating crosstalk between chemokine/chemoreceptor pathways and AR-mediated gene expression programs in prostate-cancer cells (Figure 6C). Here, CXCL11 is linked to prostate carcinoma.